Looking to publish in Cancer Biology and Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCancer Biology & Medicine is dedicated to reporting the latest advances in cancer research around the world by presenting high quality articles, especially on translational cancer research, to bridge the gap between bench and bedside. The journal promotes academic exchange in cancer between China and the rest of the world and covers topics including cancer genetics, cancer and stem cell biology, molecular and clinical immunology, cancer prevention and epidemiology, cancer biomarkers, radiation oncology, oncology clinical trials, mechanisms of drug sensitivity and resistance, targeted therapy and immunotherapy, and multidisciplinary treatment and personalized medicine.
Looking to publish in Cancer Biology and Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Cancer Biology and Medicine accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review
Minireview
Letter To The Editor
Practice Guideline
Recent Publications
Genetic susceptibility, environmental risk factors, and incident gastric cancer risk among individuals with different Helicobacter pylori infection status: a population-based study
Hengmin Xu, Hui Ma, Yuxin Wang, Xinling Wang, Xuan Han, Wenjing Zhao, Yang Zhang, Tong Zhou, Jingying Zhang, Weicheng You, Wenqing Li, Kaifeng Pan
The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer
Ruoqing Wang, Shuhao Jiang, Qun Zhang, Junjie Li
Vitamin D potentiates STING agonist-induced antitumor immunity in NSCLC
Ke Li, Guichao Liu, Wenhui Yuan, Xinhai Zhu, Peng Li
Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali, Sunny H. Wong
Exosomal B7H3 drives immunosuppression and serves as a biomarker for PD-1 blockage response in head and neck squamous cell carcinoma
Wen Wang, Chulong Xie, Juncong Luo, Leru Kuang, Yihong Wu, Nini Li, Xiaoli Liu, Xiaoyu Feng, Zizi Li, Zhanyu Li, Hongyu Zhang, Jiaoping Mi, Qi Zeng
Frequently asked questions
How long does it take to publish?
Revised manuscripts should be submitted within two months after authors receive reviewers' comments. The journal generally allows only one round of revision.
Reformat to Cancer Biology and Medicine using Livewrite PremiumIs a cover letter required?
A cover letter is required for each submission. It should include the manuscript title, a brief summary of significant findings, a statement of exclusive submission and no plagiarism or other misconduct, a statement that all authors approved the submission, the corresponding author's contact information, and suggested reviewer inclusions or exclusions.
Reformat to Cancer Biology and Medicine using Livewrite PremiumWhat are the publication costs?
Most journals are Gold Open Access. Article processing charges may be required only after a manuscript is editorially accepted and before publication; journal-specific APCs vary by journal.
Reformat to Cancer Biology and Medicine using Livewrite Premium